Member Info for Aldebaran

Hahahaha Ade, I couldn't care less what you post and where. Go for it. I mean it.

I'm not going to stop posting here.

I been here years you can scroll back on my post history and see for yourself.

As for not understanding the business your right. After years of lies and false starts im perplexed what AFC do other than heavily discounted placings.

I understand enough thanks but things have moved on a bit since my initial investment and again if you actually read my posts I've said I like John and think he has a good shot at turning it around. I just believe it will be expensive and take much longer than the rampers here are saying and its no certainty the plan will work.

All facts and valid opinions just because you dont like them and have no counter other than to "threaten" to post at avacta, doesn't make them untrue lol

Friedman. Yes look on website, look on YouTube and read rns's however the delivery system is depositing drug into tumours at a ratio of 100-1 (tumour/plasma) and in salivary gland cancer we are seeing over 90% disease control rate in patience who are heavily pre treated and in God's waiting room. Too much to go into but in short, this thing bloody works is working and has worked for 4 years.

Don't know what I'm talking about? I been here years mate. I was once like you guys, hooked on hydrogen hype and couldn't see anything but a hugely positive outcome for AFC. Just injecting a dose of reality. People need it i think. I mean just look at the share price, does it look like a huge order is imminent?? Lol

And as for me promoting pump and dumps? Care to elaborate with actual facts and research you've done on HEMO or Avacta which is the companies I presume you refer.

Probably because your so used to seeing stocks slide into the abyss like afc, that ones that are genuinely re-rating upwards off the back of several game-changing RNS's look like pump and dumps to you? Take your head out the sand

IF a huge order is announced, IF this happens, IF that happens... heard it all before and not just here.

It's hope hype and potential... afc need to ramp up sales. Enough said. And I dont care if I'm underwater I'm just speaking my true opinion. Whether it helps or not I dont care. If I lose the small amount invested on the back of years of lies it won't hurt

People scan for stocks that are making yearly highs and HEMO just did that on phenomenal volume. Definitely has loads of headroom above for a monster move!

2 stocks I'm in, avacta up 150% in past few months and HEMO, up 300% in past few days. Both just beginning there ramps up

That kind of thing will happen here if all goes well but it'll be 2027. Meanwhile, is it smart to let money just sit here doing nothing for over a year and half? Everything else is getting more expensive due to inflation and compounding that is a share price more likely to fall over the short to medium term. Eroding the value of your money.

I only have a small amount her thankfully but if it was anything sizeable id have it out and be growing it elsewhere. Other stocks are moving and moving fast !

Yes, can see it a mile off. I timed my entry last week also after watching for a while. Soon as that 180p resistance was broke with volume it gave a great signal and now clear as day to me its headed for 2,000p or perhaps closer to 2,400p (100m valuation).

I dont think this will pause until around 2,000p or around 100m market cap and then the market will trade sideways waiting for the next catalysts. This is simply regaining lost ground and given trial results and short duration now to commercialisation a 100m valuation is moretl than justified plus there is not a lot stopping it from a technical POV.

to go from 100m upwards though will need concrete news. Which is what I hope vlad is working on with some kind of RNS or webinar planned after cohort 1 completes giving us a full and detailed update.

Lying? I posted a link with a timestamp to the exact moment he said it.

I think your the one lying and in fantasy land being overly positive trying to ramp this to anyone who will listen. 28 days from last director buys will be huge you said?

You just talk 💩

No I dont want to be correct. But I am and I'm heavily underwater. As I've said its just not worth cutting now.

The potential for hydrogen is obviously huge and there is a chance JW can turn this around hence why I still keep an eye on things and check in here. I'll add and average down once I see real material signs this has turned a corner and that means none of the hairy fairy relationships with this or that company nonsense or even projected sales of this that and the other, it means significant revenue increases.

This company has wasted enough if mine and others money and if it intends to raise again which clearly it does then it needs to give good justification why anyone should continue to support it.

Let's not give rise to it. Or reignite the conversation. Ignored is the best strategy with him and or starting new threads. Let him talk to himself. The guy is a parasite

Hedge good and humble post. Retail investors are always too ambitious with there timelines. But now we are at the point where cohort one results are imminent and will be a excellent and statistically significant indication of how well this treatment will perform. It'll get gobbled up by big pharma. I suspect if not around ASH in December It'll be in Q1 2026 with more adult cohort data at the increased dose, longer term survival data for the first adult cohort and pediatric data.

I think I'm more realistic than most, having been accused of being short an deramping etc but even i can see the buyout is a matter of months away at most and likely price will rise strongly ahead of this so its blue skies ahead IMHO

What on Earth are you talking about team bashing?

I knew i remembered Bond telling us there was a CONTRACTED order book which he clearly did if you listen and the we have a new CEO takeover, one who has made a good initial impression on me I will say and he says there wasn't a contracted order book.

Which one of them is lying? I suspect it was Bond but we dont know. Point being, you cant trust any of these and there projections. We all know what AFC are and what there ambition is, now we need to see it in the accounts. The time for talk is over.

Ive lost count of the number of MoU's or JV's or site visit or discussion or partnership or expression of interest etc these have had. Just SELL SOMETHING.

Even the deal with TAMGO is not leading to anything. That huge Neom project there building in Saudi aren't using AFC why????

It all just doesn't add up to me and so I come here to discuss with others but instead of rational counter arguments you accuse me and others of bashing. Bizzare

Heights have allowed us to defer our CLN payments to 2027. That is material as it minimises dilution. Their conversion price lowered to 75p which would be a total of 27m shares so they can potentially make a fortune on those. Im sure they've been tipped off about the strength of the data and likelihood of commercial deal and important a significant rising share price expectation as have the new HNWI's who have invested. That RNS was highly significant and indicative of the direction and confidence the company is growing. Placing over subscribed and done early also and remember the price "rise" is nothing more than regaining old ground. It has a LOT of catch up to do to even begin to factor in the enormous strides and progress the company has made in recent times.

Belief and sentiment is coming back. I think this really motors now

I am positive now..I think if you look back at my posts I was only saying that funding needed sorting and the technicals needed to improve. Both those things happened so I'm happy.

ASH in Decemer but I'm hoping / expecting to get a update from Vlad after cohort 1 completes.

All I was trying to say is that providing a scientific overview and a investment overview are 2 different things. As HEMO evolves with science becoming more derisked as time goes on, we and Vlad need to start thinking of the other aspects to a investment such as communication, minimising dilution, commercial road map, crown jewels defence potentially comes into play etc. Etc...

54 minutes in. Bond clearly says that the projected revenues of just under 27m are from the CONTRACTED order book yet recently in the latest Webinar John said they revenue projections were non contractual and infact said they are going to CHANGE the way it is reported to reflect that. So either Bond or John is not being truthful. We're they contracted but then cancelled? Just what is going on. There is grounds here for a lawsuit i believe

https://youtu.be/4oa5O_GN_K4?si=gqPpQsxkO-Hry4U3

Thats rough. Im at work and dont have my notes with me.

Feel free to add meet on the bones

Zero debt

Less than 5m shares in issue

Trading above 200dma on the back of the highest weekly volume ever indicating start of a new bulltrend

Cashed up until after Christmas with HNWI promising further funding is not an issue

Recent fundraises done at premiums

Phase 1 trial gone exceptionally well with cohort 1 due to complete within next 14 days (CEO has stated this is when commercial discussions get real or words to that affect

There is no treatment options for these patients which HEMO is treating so they're shooting at an open goal

M&A in this space shows the scope and magnitude of deals made in the hundreds of millions to the billions.

Gileads acquisition of fortySeven is an example where share price traded between 5 & 9 dollar and below for years then within 4 months it hit 95 dollars and was taken out

Big Pharma all have huge patent cliffs and tens of billions of revenue they need to replace over next 5 years

Plus they have over 1tr set aside for M&A purposes.

Hemo has a unique product, saving lives in patience with no other treatment options and their doing it with little to no side effects so far. At a 24m valuation and downside protected, the investment case is compelling. DYOR

Agree gitfinger but if you have 28 days from last director buys are going to be explosive didnt you know ? 🤣

Like I said, this is a show me story now. Not show me your plans or your order book but show me actual and meaningful ramp up in sales.. then things might turn. Until then which will be 2027, this might have the odd pop and drop but largely it'll be dead money here IMO and I say that as a holder of stock at a much higher price

A very long winded and boring couple of posts. You think new investors are all PHD's in biology. Ffs you lot take some advice and keep things simple and concise. Also, an overview of the investment case should include target market, comparative deal precedents, the significance of the P3 28 day milestone regarding commercialisation, cash position etc..

This is a problem here, like Vlad, you all just focus purely on the science which is only a part of the INVESTMENT case